Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastric mucosal barrier is a multifaceted defense system in the stomach that protects against self-digestion by acid and pepsin. It consists of a mucus layer rich in mucin glycoproteins and bicarbonate ions, secreted by specialized epithelial cells. The mucus traps water, excludes large molecules, and resists proteolysis, while bicarbonate neutralizes acid near the epithelial surface, maintaining a near-neutral pH despite an acidic lumen. Damage or dysfunction of this barrier can lead to gastritis or ulceration.
NSAIDs inhibit prostaglandin synthesis, reducing bicarbonate and mucin secretion. Cimetidine reduces acid secretion which indirectly can affect bicarbonate secretion. Misoprostol is a synthetic prostaglandin E1 analog that can increase mucin and bicarbonate secretion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric Mucosal Barrier (Mucin/Bicarbonate Secretion).